Biomerica Statistics
Total Valuation
Biomerica has a market cap or net worth of $5.46 million. The enterprise value is $3.34 million.
Important Dates
The next estimated earnings date is Tuesday, January 14, 2025, before market open.
Earnings Date | Jan 14, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Biomerica has 16.82 million shares outstanding. The number of shares has increased by 11.52% in one year.
Current Share Class | 16.82M |
Shares Outstanding | 16.82M |
Shares Change (YoY) | +11.52% |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | 7.22% |
Owned by Institutions (%) | 12.06% |
Float | 15.61M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 0.99 |
Forward PS | n/a |
PB Ratio | 1.02 |
P/TBV Ratio | 1.06 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 0.61 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.00, with a Debt / Equity ratio of 0.13.
Current Ratio | 3.00 |
Quick Ratio | 2.03 |
Debt / Equity | 0.13 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -76.48% and return on invested capital (ROIC) is -45.59%.
Return on Equity (ROE) | -76.48% |
Return on Assets (ROA) | -38.54% |
Return on Capital (ROIC) | -45.59% |
Revenue Per Employee | $86,078 |
Profits Per Employee | -$96,281 |
Employee Count | 64 |
Asset Turnover | 0.52 |
Inventory Turnover | 2.63 |
Taxes
In the past 12 months, Biomerica has paid $23,000 in taxes.
Income Tax | 23,000 |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -64.75% in the last 52 weeks. The beta is -1.14, so Biomerica's price volatility has been lower than the market average.
Beta (5Y) | -1.14 |
52-Week Price Change | -64.75% |
50-Day Moving Average | 0.33 |
200-Day Moving Average | 0.57 |
Relative Strength Index (RSI) | 42.85 |
Average Volume (20 Days) | 334,124 |
Short Selling Information
The latest short interest is 562,409, so 3.34% of the outstanding shares have been sold short.
Short Interest | 562,409 |
Short Previous Month | 373,666 |
Short % of Shares Out | 3.34% |
Short % of Float | 3.60% |
Short Ratio (days to cover) | 2.28 |
Income Statement
In the last 12 months, Biomerica had revenue of $5.51 million and -$6.16 million in losses. Loss per share was -$0.37.
Revenue | 5.51M |
Gross Profit | 488,000 |
Operating Income | -6.50M |
Pretax Income | -6.30M |
Net Income | -6.16M |
EBITDA | -6.42M |
EBIT | -6.50M |
Loss Per Share | -$0.37 |
Full Income Statement Balance Sheet
The company has $2.82 million in cash and $707,000 in debt, giving a net cash position of $2.11 million or $0.13 per share.
Cash & Cash Equivalents | 2.82M |
Total Debt | 707,000 |
Net Cash | 2.11M |
Net Cash Per Share | $0.13 |
Equity (Book Value) | 5.35M |
Book Value Per Share | 0.32 |
Working Capital | 4.29M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$5.03 million and capital expenditures -$30,000, giving a free cash flow of -$5.06 million.
Operating Cash Flow | -5.03M |
Capital Expenditures | -30,000 |
Free Cash Flow | -5.06M |
FCF Per Share | -$0.30 |
Full Cash Flow Statement Margins
Gross margin is 8.86%, with operating and profit margins of -118.04% and -111.85%.
Gross Margin | 8.86% |
Operating Margin | -118.04% |
Pretax Margin | -111.44% |
Profit Margin | -111.85% |
EBITDA Margin | -116.57% |
EBIT Margin | -118.04% |
FCF Margin | -98.18% |